Aspire Private Capital’s Chemours CC Stock Holding History

Aspire Private Capital’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-58	Closed	-$2K	–	639
2021 Q3	$2K	Hold	58	–	–	﹤0.01%	480
2021 Q2	$2K	Hold	58	–	–	﹤0.01%	482
2021 Q1	$2K	Hold	58	–	–	﹤0.01%	455
2020 Q4	$1K	Hold	58	–	–	﹤0.01%	408
2020 Q3	$1K	Buy	+58	New	+$1.12K	﹤0.01%	411
2020 Q1	–	Sell	-58	Closed	-$1K	–	268
2019 Q4	$1K	Hold	58	–	–	﹤0.01%	416
2019 Q3	$1K	Hold	58	–	–	﹤0.01%	392
2019 Q2	$1K	Hold	58	–	–	﹤0.01%	431
2019 Q1	$2K	Hold	58	–	–	﹤0.01%	422
2018 Q4	$2K	Buy	+58	New	+$1.83K	﹤0.01%	403

Other funds holding CC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Aspire Private Capital's CC Position: Q4 2021 in Review

Aspire Private Capital sold out of Chemours (CC) in Q4 2021, closing a stake of 58 shares — an estimated $2K sold.

Aspire Private Capital first reported a position in CC in Q4 2018 and held it in 10 quarters. The position peaked at $2K in Q3 2021. 504 funds tracked by Wall St. Rank hold CC as of Q4 2021.

Aspire Private Capital reported no remaining Chemours position as of Q4 2021 after selling out during the quarter.
Aspire Private Capital sold 58 Chemours shares in Q4 2021, an estimated $2K.
Aspire Private Capital first reported a position in Chemours in Q4 2018 and held it in 10 quarters.
Aspire Private Capital's Chemours position peaked at $2K in Q3 2021.
504 funds tracked by Wall St. Rank held Chemours as of Q4 2021.

Based on Aspire Private Capital's 13F filing for Q4 2021, filed 14 Feb 2022.